mothertobaby semaglutide fact sheet pregnancy 2024 Ep. 84 - GLP-1 Medications in and Breastfeeding - The Podcast Semaglutide and Breastfeeding - Is

PP analysis (32 participants in the semaglutide group and 25 participants in the placebo group) showed greater percentage change in adjusted body weight in the semaglutide group compared to the placebo group (mean (s.e.), 18.5% (2.1) versus 1.10 (2.2), respectively) with an adjusted mean difference of 19.6% (95% CI 15.6 to 23.5

In the latest trials, participants had an average BMI of 37 and were mostly women with a median age of 50

Adverse effects observed in clinical trials include: Gastrointestinal effects: nausea, vomiting, diarrhoea, and constipation particularly during dose escalation

The door is exposed to more temperature swings, movement, and light

Damit fehlt ihm der gesamte regulatorische Rahmen aus Qualittskontrolle, standardisierter Dosierung und berwachter Sicherheitsbewertung, der zugelassene Medikamente auszeichnet